FDA Inspection 1009792 — Henrique N. S. Bittencourt, MD, PhD
The FDA completed an inspection of Henrique N. S. Bittencourt, MD, PhD on March 31, 2017 in Montreal. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 31, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Montreal (Canada)
Additional Details
Clinical Investigator (CI)